RMP-A03 Ocular Suspension in Patients With Pterygium
Public ClinicalTrials.gov record NCT05794204. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1/2a Study Evaluating the Safety and Efficacy of RMP-A03 Ocular Suspension in Healthy Volunteers and Patients With Pterygium
Study identification
- NCT ID
- NCT05794204
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Suzhou Raymon Pharmaceuticals Company, Ltd.
- Industry
- Enrollment
- 77 participants
Conditions and interventions
Conditions
Interventions
- RMP-A03 - Dose 1 Drug
- RMP-A03 - Dose 2 Drug
- RMP-A03 Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 8, 2023
- Primary completion
- Jan 11, 2024
- Completion
- Jan 11, 2024
- Last update posted
- Jun 4, 2026
2023 – 2024
United States locations
- U.S. sites
- 6
- U.S. states
- 4
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Global Research Management | Glendale | California | 91204 | — |
| United Medical Research Institute | Inglewood | California | 90301 | — |
| Eye Research Foundation Inc | Newport Beach | California | 92663 | — |
| Oceane7 Medical & Research Center Inc. | Miami | Florida | 33144 | — |
| Toyos Clinic | Nashville | Tennessee | 37215 | — |
| Keystone Research | Austin | Texas | 78731 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05794204, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 4, 2026 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05794204 live on ClinicalTrials.gov.